

Rigel Pharmaceuticals develops small-molecule drugs for the treatment of autoimmune diseases, cancer and metabolic diseases. Among its major competitors, Rigel Pharmaceuticals is ranked in 6th place for NPS while Roche is 1st, and Genentech is 2nd.Their current market cap is $272.66M